JAK2 and neoplasm: Not only immunogenic neoantigens, but also mutations in immunologically relevant genes, can affect the ability of T cells to identify and kill tumor cell, for example; mutations in JAK1, JAK2, B2M, and STK11genes (Skoulidis et al., 2018).